ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for discussion 登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。

NEXI NexImmune Inc

3.32
0.20 (6.41%)
2024年5月4日 - 終了
15分遅延
名称 銘柄コード 市場 種別
NexImmune Inc NEXI NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
0.20 6.41% 3.32 13:00:06
始値 安値 高値 終値 前日終値
3.13 3.10 3.4899 3.32 3.12
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/3/0803:20BWKonzernergebnis zum 31. Dezember 2023 genehmigt, starke..
2024/3/0802:33BWApprobation des résultats financiers du groupe au 31..
2024/3/0715:31BWApprovati i risultati finanziari di Gruppo al 31 dicembre..
2024/3/0715:30BWGroup Financial Results as of December 31st 2023 Approved,..
2024/2/0706:42GLOBENexImmune Announces Closing of $3.67 Million Registered..
2024/2/0706:30EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
2024/2/0607:10EDGAR2Form 8-K - Current report
2024/2/0606:34EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
2024/2/0304:00GLOBENexImmune Announces $3.67 Million Registered Direct Offering..
2024/2/0303:25EDGAR2Form 8-K - Current report
2024/2/0123:17EDGAR2Form 8-K - Current report
2024/1/2006:43EDGAR2Form 8-K - Current report
2024/1/1906:43EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
2023/12/2306:01EDGAR2Form 8-K - Current report
2023/12/0203:39EDGAR2Form 8-K - Current report
2023/11/2307:40EDGAR2Form 144/A - Report of proposed sale of securities: [Amend]
2023/11/2307:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/11/2206:39EDGAR2Form 144 - Report of proposed sale of securities
2023/11/2107:19EDGAR2Form DEF 14A - Other definitive proxy statements
2023/11/2107:01EDGAR2Form 8-K/A - Current report: [Amend]
2023/11/1806:03EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/1606:17EDGAR2Form NT 10-Q - Notification of inability to timely file Form..
2023/11/1007:47EDGAR2Form PRE 14A - Other preliminary proxy statements
2023/11/0923:35BWFinanzergebnisse der Gruppe zum 30. September 2023..
2023/11/0922:52BWLes résultats financiers du groupe au 30 septembre 2023 ont..
2023/11/0915:30BWApprovati I Risultati Finanziari Di Gruppo Al 30 Settembre..
2023/11/0306:12EDGAR2Form 8-K - Current report
2023/11/0305:33EDGAR2Form 8-K - Current report
2023/10/2421:00GLOBENexImmune, Yale, and JDRF Extend Research Partnership for..
2023/10/1921:00GLOBENexImmune Announces Presentations at The Society for..
2023/10/1905:15EDGAR2Form 8-K - Current report
2023/10/1900:30GLOBENexImmune Announces 1-for-25 Reverse Stock Split
2023/9/2605:42EDGAR2Form DEF 14A - Other definitive proxy statements
2023/9/1605:06EDGAR2Form 8-K - Current report
2023/9/1406:14EDGAR2Form PRE 14A - Other preliminary proxy statements
2023/9/0908:23EDGAR2Form 3 - Initial statement of beneficial ownership of..
2023/9/0106:11EDGAR2Form 8-K - Current report
2023/9/0105:45GLOBENexImmune Announces Workforce Reduction to Enable Continued..
2023/8/1105:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/8/1105:06EDGAR2Form 8-K - Current report
2023/8/1105:01GLOBENexImmune Reports Second Quarter 2023 Financial Results and..
2023/8/0207:21BWFinanzergebnisse der Gruppe zum 30. Juni 2023 bestätigen..
2023/8/0114:23BWGroup Financial Results as of June 30th 2023, Approved Solid..
2023/7/0805:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/7/0805:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/7/0805:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/7/0805:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/6/0521:01GLOBENexImmune Presents Initial Positive Data from the NEXI-001..
2023/5/2305:01GLOBENexImmune Announces Poster Presentation at the 2023 FOCIS..
2023/5/1605:01GLOBENexImmune Reports First Quarter 2023 Financial Results and..

最近閲覧した銘柄

Delayed Upgrade Clock